Abstract: DWP-450, Purified Botulinum Toxin Type A, for the Treatment of Moderate-to-Severe Glabellar Lines in Adult Subjects: Results from a Multi-Center, Open Label, Repeat Dose, Long Term Exposure, Year Long Phase II Safety Study

Detalles Bibliográficos
Autor principal: Lorenc, Z. Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
PSTM 2017 Abstract Supplement
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5636565/
http://dx.doi.org/10.1097/01.GOX.0000526444.68948.f7
_version_ 1783270476986974208
author Lorenc, Z. Paul
author_facet Lorenc, Z. Paul
author_sort Lorenc, Z. Paul
collection PubMed
description
format Online
Article
Text
id pubmed-5636565
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-56365652017-10-17 Abstract: DWP-450, Purified Botulinum Toxin Type A, for the Treatment of Moderate-to-Severe Glabellar Lines in Adult Subjects: Results from a Multi-Center, Open Label, Repeat Dose, Long Term Exposure, Year Long Phase II Safety Study Lorenc, Z. Paul Plast Reconstr Surg Glob Open PSTM 2017 Abstract Supplement Wolters Kluwer Health 2017-10-02 /pmc/articles/PMC5636565/ http://dx.doi.org/10.1097/01.GOX.0000526444.68948.f7 Text en Copyright © 2017 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of The American Society of Plastic Surgeons. All rights reserved. This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (http://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle PSTM 2017 Abstract Supplement
Lorenc, Z. Paul
Abstract: DWP-450, Purified Botulinum Toxin Type A, for the Treatment of Moderate-to-Severe Glabellar Lines in Adult Subjects: Results from a Multi-Center, Open Label, Repeat Dose, Long Term Exposure, Year Long Phase II Safety Study
title Abstract: DWP-450, Purified Botulinum Toxin Type A, for the Treatment of Moderate-to-Severe Glabellar Lines in Adult Subjects: Results from a Multi-Center, Open Label, Repeat Dose, Long Term Exposure, Year Long Phase II Safety Study
title_full Abstract: DWP-450, Purified Botulinum Toxin Type A, for the Treatment of Moderate-to-Severe Glabellar Lines in Adult Subjects: Results from a Multi-Center, Open Label, Repeat Dose, Long Term Exposure, Year Long Phase II Safety Study
title_fullStr Abstract: DWP-450, Purified Botulinum Toxin Type A, for the Treatment of Moderate-to-Severe Glabellar Lines in Adult Subjects: Results from a Multi-Center, Open Label, Repeat Dose, Long Term Exposure, Year Long Phase II Safety Study
title_full_unstemmed Abstract: DWP-450, Purified Botulinum Toxin Type A, for the Treatment of Moderate-to-Severe Glabellar Lines in Adult Subjects: Results from a Multi-Center, Open Label, Repeat Dose, Long Term Exposure, Year Long Phase II Safety Study
title_short Abstract: DWP-450, Purified Botulinum Toxin Type A, for the Treatment of Moderate-to-Severe Glabellar Lines in Adult Subjects: Results from a Multi-Center, Open Label, Repeat Dose, Long Term Exposure, Year Long Phase II Safety Study
title_sort abstract: dwp-450, purified botulinum toxin type a, for the treatment of moderate-to-severe glabellar lines in adult subjects: results from a multi-center, open label, repeat dose, long term exposure, year long phase ii safety study
topic PSTM 2017 Abstract Supplement
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5636565/
http://dx.doi.org/10.1097/01.GOX.0000526444.68948.f7
work_keys_str_mv AT lorenczpaul abstractdwp450purifiedbotulinumtoxintypeaforthetreatmentofmoderatetosevereglabellarlinesinadultsubjectsresultsfromamulticenteropenlabelrepeatdoselongtermexposureyearlongphaseiisafetystudy

Ejemplares similares